How Highly Multiplexed Immunofluorescent Labeling Service Transforms Biomarker Profiling
In the world of drug discovery and development, the ability to accurately profile biomarkers within tissues is crucial for [...]
Visikol Multiplex Technology and the Drug Discovery Process
Consumers across the world benefit from having access to the safest and most advanced drug discovery system. Every country [...]
Multiplex Cell Painting Assay for Pathological Diagnosis of Cells
Many human diseases are caused by morphological, physiological or genetic changes in cells. The challenges of disease diagnosis include [...]
How Many Markers are the Right Amount for Multiplex Tissue Imaging?
In the last few years, there has been an explosion in the number of platforms for multiplex tissue imaging [...]
Clinical Implications of Multiplex Imaging
In 2021, over 1,000,000 new cases of cancer and over 600,000 cancer deaths are projected to occur in the [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
High Content Screening for Immune Modulators
Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]